Several inflammatory signaling pathways, such as NF-κB, JAK/STAT, and PI3K/AKT, provide prosurvival and proliferative signals to developing CRC cells, and genetic inhibition of these pathways uniformly reduces inflammation and tumor number (20, 22, 74). Here, AKT1 is linked to colorectal carcinoma.